Literature DB >> 12010927

Myocardial dysfunction in sepsis: no role for NO?

E Belcher, J Mitchell, T Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12010927      PMCID： PMC1767140          DOI： 10.1136/heart.87.6.507

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  24 in total

1.  Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.

Authors:  G Müller-Strahl; K Kottenberg; H G Zimmer; E Noack; G Kojda
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 2.  Cyclic AMP phosphodiesterases and Ca2+ current regulation in cardiac cells.

Authors:  R Fischmeister; H C Hartzell
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

Review 3.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 4.  Pharmacologic enhancement of tolerance to ischemic cardiac stress using monophosphoryl lipid A. A comparison with antecedent ischemia.

Authors:  L Zhao; G T Elliott
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

5.  Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin.

Authors:  U Grandel; U Sibelius; J Schrickel; D Schmidt; M Buerke; L Fink; E Bournelis; M Heep; K Mayer; R M Bohle; W Seeger; F Grimminger
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

6.  Profound but reversible myocardial depression in patients with septic shock.

Authors:  M M Parker; J H Shelhamer; S L Bacharach; M V Green; C Natanson; T M Frederick; B A Damske; J E Parrillo
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

7.  The coronary circulation in human septic shock.

Authors:  R E Cunnion; G L Schaer; M M Parker; C Natanson; J E Parrillo
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

8.  Endotoxemia in human septic shock.

Authors:  R L Danner; R J Elin; J M Hosseini; R A Wesley; J M Reilly; J E Parillo
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

9.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

Authors:  Angel López; Jose Angel Lorente; Jay Steingrub; Jan Bakker; Angela McLuckie; Sheila Willatts; Michael Brockway; Antonio Anzueto; Laurent Holzapfel; Desmond Breen; Michael S Silverman; Jukka Takala; Jill Donaldson; Carl Arneson; Geraldine Grove; Steven Grossman; Robert Grover
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

10.  Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study.

Authors:  A Kimchi; A G Ellrodt; D S Berman; M S Riedinger; H J Swan; G H Murata
Journal:  J Am Coll Cardiol       Date:  1984-11       Impact factor: 24.094
View more
  9 in total

1.  Cardiovascular management of septic shock in 2012.

Authors:  Maria Cristina Vazquez Guillamet; Chanu Rhee; Andrew J Patterson
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

Review 2.  Molecular events in the cardiomyopathy of sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Markus S Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

3.  Circumferential strain rate to detect lipopolysaccharide-induced cardiac dysfunction: a speckle tracking echocardiography study.

Authors:  Ming Chu; Lijun Qian; Menglin Zhu; Jing Yao; Di Xu; Minglong Chen
Journal:  Quant Imaging Med Surg       Date:  2019-02

Review 4.  Bench-to-bedside review: sepsis - from the redox point of view.

Authors:  Michael Éverton Andrades; Arian Morina; Snežana Spasić; Ivan Spasojević
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

Review 5.  Experimental treatments for mitochondrial dysfunction in sepsis: A narrative review.

Authors:  Guilang Zheng; Juanjuan Lyu; Jingda Huang; Dan Xiang; Meiyan Xie; Qiyi Zeng
Journal:  J Res Med Sci       Date:  2015-02       Impact factor: 1.852

Review 6.  Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders.

Authors:  Karolina M Stepien; Robert Heaton; Scott Rankin; Alex Murphy; James Bentley; Darren Sexton; Iain P Hargreaves
Journal:  J Clin Med       Date:  2017-07-19       Impact factor: 4.241

Review 7.  Potential therapy strategy: targeting mitochondrial dysfunction in sepsis.

Authors:  Hui Zhang; Yong-Wen Feng; Yong-Ming Yao
Journal:  Mil Med Res       Date:  2018-11-26

Review 8.  Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis.

Authors:  Wendy A Luce; Timothy M Hoffman; John Anthony Bauer
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 9.  Sirtuins and Sepsis: Cross Talk between Redox and Epigenetic Pathways.

Authors:  Anugraha Gandhirajan; Sanjoy Roychowdhury; Vidula Vachharajani
Journal:  Antioxidants (Basel)       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.